X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with AJANTA PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs AJANTA PHARMA - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS AJANTA PHARMA J.B.CHEMICALS/
AJANTA PHARMA
 
P/E (TTM) x 15.9 28.9 55.1% View Chart
P/BV x 2.5 11.9 21.1% View Chart
Dividend Yield % 0.2 0.5 30.6%  

Financials

 J.B.CHEMICALS   AJANTA PHARMA
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-16
AJANTA PHARMA
Mar-16
J.B.CHEMICALS/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs3181,720 18.5%   
Low Rs2001,103 18.1%   
Sales per share (Unadj.) Rs148.0194.6 76.0%  
Earnings per share (Unadj.) Rs19.145.2 42.2%  
Cash flow per share (Unadj.) Rs23.950.3 47.6%  
Dividends per share (Unadj.) Rs0.508.00 6.3%  
Dividend yield (eoy) %0.20.6 34.1%  
Book value per share (Unadj.) Rs128.9132.0 97.7%  
Shares outstanding (eoy) m84.8288.77 95.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.77.3 24.1%   
Avg P/E ratio x13.631.2 43.4%  
P/CF ratio (eoy) x10.828.1 38.5%  
Price / Book Value ratio x2.010.7 18.8%  
Dividend payout %2.617.7 14.8%   
Avg Mkt Cap Rs m21,951125,299 17.5%   
No. of employees `0002.7NA-   
Total wages/salary Rs m1,8412,570 71.6%   
Avg. sales/employee Rs Th4,590.9NM-  
Avg. wages/employee Rs Th673.4NM-  
Avg. net profit/employee Rs Th592.1NM-  
INCOME DATA
Net Sales Rs m12,55117,275 72.7%  
Other income Rs m542166 325.7%   
Total revenues Rs m13,09317,442 75.1%   
Gross profit Rs m2,0555,807 35.4%  
Depreciation Rs m412451 91.5%   
Interest Rs m9649 195.7%   
Profit before tax Rs m2,0885,474 38.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4691,460 32.1%   
Profit after tax Rs m1,6194,014 40.3%  
Gross profit margin %16.433.6 48.7%  
Effective tax rate %22.526.7 84.2%   
Net profit margin %12.923.2 55.5%  
BALANCE SHEET DATA
Current assets Rs m7,7787,639 101.8%   
Current liabilities Rs m4,3582,715 160.5%   
Net working cap to sales %27.228.5 95.6%  
Current ratio x1.82.8 63.4%  
Inventory Days Days5543 126.5%  
Debtors Days Days8079 101.7%  
Net fixed assets Rs m5,7136,914 82.6%   
Share capital Rs m170177 95.9%   
"Free" reserves Rs m10,54711,442 92.2%   
Net worth Rs m10,93711,721 93.3%   
Long term debt Rs m0149 0.0%   
Total assets Rs m15,57414,814 105.1%  
Interest coverage x22.8112.9 20.2%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.81.2 69.1%   
Return on assets %11.027.4 40.1%  
Return on equity %14.834.2 43.2%  
Return on capital %20.046.5 42.9%  
Exports to sales %48.755.1 88.3%   
Imports to sales %7.16.0 117.9%   
Exports (fob) Rs m6,1159,527 64.2%   
Imports (cif) Rs m8891,038 85.6%   
Fx inflow Rs m6,16910,422 59.2%   
Fx outflow Rs m1,2851,678 76.6%   
Net fx Rs m4,8848,744 55.9%   
CASH FLOW
From Operations Rs m1,3973,264 42.8%  
From Investments Rs m-320-2,093 15.3%  
From Financial Activity Rs m-1,196-1,186 100.9%  
Net Cashflow Rs m-102-15 691.2%  

Share Holding

Indian Promoters % 55.4 73.8 75.1%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 1.6 218.7%  
FIIs % 3.9 7.6 51.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 17.0 217.6%  
Shareholders   30,437 20,968 145.2%  
Pledged promoter(s) holding % 0.0 4.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   UNICHEM LAB  AUROBINDO PHARMA  IPCA LABS  WOCKHARDT LTD.  TORRENT PHARMA  

Compare J.B.CHEMICALS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty at Record Close Yet Again; IT & Realty Stocks Rally(Closing)

Indian share markets extended rally in the final hour of the trade, hitting fresh record highs while the Bank nifty touched 27,000 level for the first time. At the closing bell.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Jan 22, 2018 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS - TORRENT PHARMA COMPARISON

COMPARE J.B.CHEMICALS WITH

MARKET STATS